title: Brain amyloid imaging--FDA approval of florbetapir F18 injection.
authors.affiliation: Division of Medical Imaging Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
authors.forename: Lucie
authors.initials: L
authors.lastname: Yang
authors.forename: Dwaine
authors.initials: D
authors.lastname: Rieves
authors.forename: Charles
authors.initials: C
authors.lastname: Ganley
mesh_terms: D000544:Alzheimer Disease / Q000000981:diagnostic imaging* / Q000473:pathology; D016229:Amyloid beta-Peptides; D000814:Aniline Compounds; D001921:Brain / Q000000981:diagnostic imaging* / Q000473:pathology; D003072:Cognition Disorders / Q000000981:diagnostic imaging*; D003937:Diagnosis, Differential; D017277:Drug Approval; D005026:Ethylene Glycols; D005462:Fluorine Radioisotopes; D007267:Injections; D058225:Plaque, Amyloid / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016229:Amyloid beta-Peptides; D000814:Aniline Compounds; D005026:Ethylene Glycols; D005462:Fluorine Radioisotopes; C545186:florbetapir